Scholars Central

Research articlePublished 2017

WPLYW CETUKSYMABU NA PROCES APOPTOZY I FAZY CYKLU KOMOREK RAKA PIERSI IN VITRO

Authors: Jolanta Rzymowska, Agnieszka Zbyrad

Onkologia i Radioterapia

Volume 11 · Issue 1 · Pages 15–18

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The aim of the study was to check how cetuximab affects the cell cycle and apoptosis of breast cancer cells. The study was conducted on primary breast cancer cell lines and non-neoplastic cell lines derived from samples collected from patients with histopathologically diagnosed Tp1-2 Np0 Mp0 ductal carcinoma. The effect of this chemotherapeutic agent on cells in the G1, S, G2/M cell cycle phases and on apoptosis of these cells was analyzed in a flow cytometer. Cetuximab, a monoclonal antibody, at a dose of 10 and 100 μg/mL of the culture medium was used for the study. Cetuximab is capable of inducing apoptosis and inhibiting cancer cells in the S, and G2/M cell cycle phases. This cytostatic agent can constitute a potential strategy in phase-dependent treatment of breast cancer. However, it is not effective enough to be used in monotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalOnkologia i Radioterapia
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jolanta Rzymowska”
  • BylineArticles whose byline prints “Agnieszka Zbyrad”